Material
Synthetic heptapeptide analogue

Prepared for controlled studies involving neuroregulatory signaling and behavioral research models.
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Synthetic heptapeptide analogue
Single peptide material.
Neuropeptide research.
Selank is followed for its combined relevance to stress-response models, anxiety-related behavior, neurotrophic signaling, and cognitive performance research.
Stress, anxiety-related behavior, and neuroregulatory signaling
Memory, BDNF, and tuftsin-analogue biology
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
A small randomized comparative human study reported anxiolytic effects similar to medazepam in the population studied, alongside antiasthenic findings. Experimental studies also report changes in memory and neurotrophic markers.
Human evidence is small and regionally concentrated, while much of the mechanistic work remains preclinical. Independent replication across larger populations is still limited.
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Enter a positive diluent volume and target amount to calculate.
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
This is the evergreen product profile. Enter the code from a physical vial to display its specific record.
Verify this vialThis QR code opens the current product profile with its associated vial record.